Skeletal morbidity in childhood acute lymphoblastic leukaemia

Clinical Endocrinology

Volumn 63, Issue 1, 2005, Pages 1-9

  Davies, J H ^a   Evans, B A J ^a   Jenney, M E M ^b   Gregory, J W ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEXAMETHASONE; DOXORUBICIN; GLUCOCORTICOID; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AVASCULAR NECROSIS; BONE DENSITY; BONE DISEASE; BONE METABOLISM; BONE MINERAL; BONE NECROSIS; BONE PAIN; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; FRACTURE; HUMAN; IMMOBILIZATION; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; REVIEW; VITAMIN D DEFICIENCY;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HOMEOSTASIS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE;

EID: 22044450799     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02263.x     Document Type: Review

References (87)

1. Cortes, J.E. & Kantarjian, H.M. (1995) Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer, 76, 2393-2417.
2. Pui, C.H., Relling, M.V. & Downing, J.R. (2004) Acute lymphoblastic leukemia. New England Journal of Medicine, 350, 1535-1548.
3. Gueguen, R., Jouanny, P., Guillemin, F., Kuntz, C., Pourel, J. & Siest, G. (1995) Segregation analysis and variance components analysis of bone mineral density in healthy families. Journal of Bone and Mineral Research, 10, 2017-2022.
4. Simmons, C.R., Harle, T.S. & Singleton, E.B. (1968) The osseous manifestations of leukemia in children. Radiology Clinics of North America, 6, 115-130.
5. Rogalsky, R., Black, G. & Reed, M. (1986) Orthopaedic manifestations of leukemia in children. Journal of Bone and Joint Surgery, 4, 494-501.
6. Halton, J.M., Atkinson, S.A., Fraher, L., Webber, C., Cokshott, W.P., Tam, C. & Barr, R. (1995) Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. Journal of Pediatrics, 126, 557-564.
7. Heinrich, S.D., Gallagher, D., Warrior, R., Phelan, K., George, V.T. & MacEwen, G.D. (1994) The prognostic significance of the skeletal manifestations of acute lymphoblastic leukemia in childhood. Journal of Pediatric Orthopaedics, 14, 105-111.
8. Kai, T., Ishii, E., Matsuzaki, A., Okamura, J., Ikuno, Y., Tasaka, E. & Ueda, K. (1996) Clinical and prognostic implications in childhood leukemia at diagnosis. Leukemia and Lymphoma, 23, 119-123.
9. Müller, H.L., Horowitz, A.E. & Kuhl, J. (1998) Acute lymphoblastic leukemia with severe skeletal involvement. Pediatric Hematology and Oncology, 15, 121-133.
10. Crofton, P.M., Stirling, H.F., Schonau, E. et al. (1996) Biochemical markers of bone turnover. Hormone Research, 45, 55-58.
11. Sorva, R., Kivivuori, S.M., Turpeinen, M., Marttinen, E., Risteli, J., Risteli, L., Sorva, A. & Siimes, M.A. (1997) Very low rate of type I collagen synthesis and degradation in newly diagnosed children with acute lymphoblastic leukaemia. Bone, 20, 139-143.
12. Crofton, P.M., Ahmed, S.F., Wade, J.C., Stephen, R., Elmlinger, M.W., Ranke, M.B., Kelnar, C.J.H. & Wallace, W.H.B. (1998) Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. Journal of Clinical Endocrinology and Metabolism, 83, 3121-3129.
13. Samuda, G.M., Cheng, M.Y. & Yeung, C.Y. (1987) Back pain and vertebral compression: an uncommon presentation of childhood acute lymphoblastic leukemia. Journal of Pediatric Orthopaedics, 72, 175-178.
14. Halton, J.M., Atkinson, S.A., Fraher, L., Webbern, C., Gill, G.J., Dawson, S. & Barr, R.D. (1996) Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. Journal of Bone and Mineral Research, 11, 1774-1783.
15. Davies, J.H., Evans, B.A.J., Jones, E., Evans, W.D., Jenney, M.E.M. & Gregory, J.W. (2004) Osteopenia, excess adiposity and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukaemia without cranial irradiation. Clinical Endocrinology, 60, 358-365.
16. D'Angelo, P., Conter, V., Di Chiara, G., Rizzari, C., Memeo, A. & Barigozzi, P. (1993) Severe osteoporosis and multiple vertebral collapses in a child during treatment for B-ALL. Acta Haematologica, 89, 38-42.
17. Crofton, P.M., Ahmed, S.F., Wade, J.C., Elmlinger, M.W., Ranke, M.B., Kelnar, C.J. & Wallace, W.H. (1999) Effects of a third intensification block of chemotherapy on bone and collagen turnover, insulin-like growth factor I, its binding proteins and short-term growth in children with acute lymphoblastic leukaemia. European Journal of Cancer, 35, 960-967.
18. Crofton, P.M., Ahmed, S.F., Wade, J.C., Elminger, M.W., Ranke, M.B., Kelnar, C.J.H. & Wallace, W.H.B. (2000) Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia. Pediatric Research, 48, 490-496.
19. Wallace, A.M., Tucker, P., Williams, D.M., Hughes, I.A. & Ahmed, S.F. (2003) Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Clinical Endocrinology, 58, 770-776.
20. Gordeladze, J.O., Drevon, C.A., Syversen, U. & Reseland, J.E. (2002) Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. Journal of Cellular Biochemistry, 85, 825-836.
21. Boot, A.M., van den Heuvel-Eibrink, M.M., Hahlen, K., Krenning, E.P. & de Muinck Keizer-Schrama, S.M. (1999) Bone mineral density in children with acute lymphoblastic leukaemia. European Journal of Cancer, 35, 1693-1697.
22. Hahn, T.J., Halstead, L.R. & Baran, D.T. (1981) Effects off short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. Journal of Clinical Endocrinology and Metabolism, 52, 111-115.
23. Atkinson, S.A., Halton, J.M., Bradley, C., Wu, B. & Barr, R.D. (1998) Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. International Journal of Cancer Supplement, 11, 35-39.
24. Fatemi, S., Ryzen, E., Flores, J., Endres, D.B. & Rude, R.K. (1991) Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. Journal of Clinical Endocrinology and Metabolism, 73, 1067-1072.
25. Pieters, R., Klumper, E., Kaspers, G.J. & Veerman, A.J. (1997) Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia. Critical Reviews in Oncology/Hematology, 25, 11-26.
26. Lukert, B.P. & Raisz, L.G. (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Annals of International Medicine, 112, 352-364.
27. Mattano, L.A. Jr, Sather, H.N., Trigg, M.E. & Nachman, J.B. (2000) Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. Journal of Clinical Oncology, 18, 3262-3272.
28. Strauss, A.J., Su, J.T., Dalton, V.M., Gelber, R.D., Sallan, S.E. & Silverman, L.B. (2001) Bony morbidity in children treated for acute lymphoblastic leukemia. Journal of Clinical Oncology, 19, 3066-3072.
29. Ishida, Y. & Heersche, J.N. (1998) Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. Journal of Bone Mineral and Research, 13, 1822-1826.
30. Dempster, D.W., Arlot, M.A. & Meunier, P.J. (1983) Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcified Tissue International, 35, 410-417.
31. Kasperk, C., Schneider, U., Soommer, U., Niethard, F. & Ziegler, R. (1995) Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro. Calcified Tissue International, 57, 120-126.
32. Chevalley, T., Strong, D.D., Subburaman, M., Baylink, D.J. & Linkhart, T.A. (1996) Evidence for a role for insulin-like growth factor binding proteins in glucocorticoid inhibition of normal human osteoblast-like cell proliferation. European Journal of Endocrinology, 34, 591-601.
33. Suzuki, Y., Ichikawa, Y., Saito, E. & Homma, M. (1983) Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism, 32, 151-156.
34. Chesney, R.W., Mazess, R.B., Hamstra, A.J., DeLuca, H.F. & O'Reagan, S. (1978) Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids. Lancet, 25, 1123-1125.
35. Arikoski, P., Komulainen, J., Riikonen, P., Parviainen, M., Jurvelin, J., Voutilainen, R. & Kröger, H. (1999) Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. Journal of Bone and Mineral Research, 14, 2002-2009.
36. Arikoski, P., Komulainen, J., Riikonen, P., Voutilainen, R., Knip, M. & Kroger, H. (1999) Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. Journal of Clinical Endocrinology and Metabolism, 84, 3174-3181.
37. Ragab, A.H., Frech, R.S. & Vietta, T.J. (1970) Osteoporotic fractures secondary to methotrexate therapy of acute lymphoblastic leukaemia. Cancer, 25, 580-585.
38. Ecklund, K., Laor, T., Goorin, A.M., Connolly, L.P. & Jaramillo, D. (1997) Methotrexate osteopathy in patients with osteosarcoma. Radiology, 202, 543-547.
39. Pelker, R.R., Friedlaender, G.E., Panjabi, M.M., Markham, T., Hausman, M., Doganis, A.C. & McKay, J. (1985) Chemotherapy-induced alterations in the biomechanics of rat bone. Journal of Orthopaedic Research, 3, 91-95.
40. Nilsson, O.S., Persson, P.E. & Ekelund, A. (1990) Heterotopic new bone formation causes resorption of the inductive bone matrix. Clinical Orthopaedics, 257, 280-285.
41. Friedlaender, G.E., Tross, R.B., Doganis, A.C., Kirkwood, J.M. & Baron, R. (1984) Effects of chemotherapeutic agents on bone. Journal of Bone and Joint Surgery, 66, 602-607.
42. May, K.P., Mercill, D., McDermot, M.T. & West, S.G. (1996) The effect of methotrexate on mouse bone cells in culture. Arthritis and Rheumatism, 3, 489-494.
43. Manolagas, S.C. (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews, 21, 115-137.
44. 3. Journal of Bone and Mineral Research, 10, 874-880.
45. Davies, J.H., Evans, B.A.J., Jenney, M.E.M. & Gregory, J.W. (2002) In vitro effects of chemotherapeutic agents on human osteoblast-like cells. Calcified Tissue International, 70, 408-415.
46. Davies, J.H., Evans, B.A.J., Jenney, M.E.M. & Gregory, J.W. (2002) In vitro effects of combination chemotherapy on human osteoblasts: implications for osteopenia in childhood malignancy. Bone, 31, 319-326.
47. Roholl, P.J., Blauw, E., Zurcher, C., Dormans, J.A. & Theuns, H.M. (1994) Evidence for a diminished maturation of preosteoblasts into osteoblasts during aging in rats: an ultrastructural analysis. Journal of Bone and Mineral Research, 9, 355-366.
48. Davies, J.H., Evans, B.A.J., Jenney, M.E.M. & Gregory, J.W. (2003) Effects of chemotherapeutic agents on the function of primary human osteoblast-like cells derived from children. Journal of Clinical Endocrinology and Metabolism, 88, 6088-6097.
49. Meneghello, A., Presacco, D. & Di Maggio, C. (1989) Aseptic osteonecrosis of the femoral head in cancer patients with neuropathies caused by vincristine and vinblastine. La Radiologica Medica, 77, 626-630.
50. Atkinson, S.A., Fraher, L., Gundberg, C.M., Andrew, M., Pai, M. & Barr, R.D. (1989) Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. Journal of Pediatrics, 114, 793-800.
51. van der Sluis, I.M., van den Heuvel-Eibrink, M.M., Hahlen, K., Krenning, E.P. & de Muinck Keizer-Schrama, S.M. (2002) Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. Journal of Pediatrics, 141, 204-210.
52. Warner, J.T., Cowan, F.J., Dunstan, F.D., Evans, W.D., Webb, D.K. & Gregory, J.W. (1998) Measured and predicted bone mineral content in healthy boys and girls aged 6-18 years: adjustment for body size and puberty. Acta Paediatrica, 87, 244-249.
53. Kroger, H., Kotaniemi, A., Vainio, P. & Alhava, E. (1992) Bone densitometry of the spine and femur in children by dual-energy X-ray absorptiometry. Bone and Mineral, 17, 75-85.
54. Gilsanz, V., Carlston, M.E., Roe, T.F. & Ortega, J.A. (1990) Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. Journal of Pediatrics, 117, 238-244.
55. Nussey, S.S., Hyer, S.L., Brada, M. & Leiper, A.D. (1994) Bone mineralisation after treatment of growth hormone deficiency in survivors of childhood malignancy. Acta Paediatrica Supplement, 399, 9-14.
56. Henderson, R.C., Madsen, C.D., Davis, C. & Gold, S.H. (1996) Bone density in survivors of childhood malignancies. Journal of Pediatric Hematology/Oncology, 184, 367-371.
57. Kaste, S.C., Jones-Wallace, D., Rose, S.R., Boyett, J.M., Lustig, R.H., Rivera, G.K., Pui, C.H. & Hudson, M.M. (2001) Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia, 15, 728-734.
58. Nysom, K., Holm, K., Michaelsen, K.F., Hertz, H., Muller, J. & Molgaard, C. (1998) Bone mass after treatment for acute lymphoblastic leukemia in childhood. Journal of Clinical Oncology, 16, 3752-3760.
59. Leiper, A. (1995) Growth hormone deficiency in children treated for leukaemia. Acta Paediatrica Suppl, 411, 41-44.
60. Brennan, B.M.D., Rahim, A. & Adams, J.A., Eden, O.B. & Shalet, S.M. (1999) Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. British Journal of Cancer, 79, 1859-1863.
61. van der Sluis, I.M., van den Heuvel-Eibrink, M.M., Hahlen, K., Krenning, E.P. & de Muinck Keizer-Schrama, S.M. (2000) Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Medical Pediatric Oncology, 35, 415-420.
62. Tillmann, V., Darlington, A.S., Eiser, C., Bishop, N.J. & Davies, H.A. (2002) Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. Journal of Bone and Mineral Research, 17, 1073-1080.
63. Warner, J.T., Evans, W.D., Webb, D.K.H., Bell, W. & Gregory, J.W. (1999) Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatric Research, 45, 544-551.
64. Kadan-Lottick, N., Marshall, J.A., Baron, A.E., Krebs, N.F., Hambidge, K.M. & Albano, E. (2001) Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. Journal of Pediatrics, 138, 898-904.
65. Hoorweg-Nijman, J.J., Kardos, G., Roos, J.C., van Dijk, H.J., Netelenbos, C., Popp-Snijders, C., de Ridder, C.M. & Delemarre-van de Waal, H.A. (1999) Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia. Clinical Endocrinology, 50, 237-244.
66. Wheeler, D.L., Vander Griend, R.A., Wronski, T.J., Miller, G.J., Keith, E.E. & Graves, J.E. (1995) The short- and long-term effects of methotrexate on the rat skeleton. Bone, 16, 215-221.
67. Warner, J.T., Bell, W., Webb, D.K. & Gregory, J.W. (1998) Daily energy expenditure and physical activity in survivors of childhood malignancy. Pediatric Research, 43, 607-613.
68. Zeltzer, L.K., Chen, E., Weiss, R., Guo, M.D., Robison, L.L., Meadows, A.T., Mills, J.L., Nicholson, H.S. & Byrne, J. (1997) Comparison of psychologic outcome in adult survivors of childhood acute lymphoblastic leukemia versus sibling controls: a cooperative Children's Cancer Group and National Institutes of Health study. Journal of Clinical Oncology, 15, 547-556.
69. Arikoski, P., Komulainen, J., Voutilainen, R., Riikonen, P., Parviainen, M., Tapanainen, P., Knip, M. & Kroger, H. (1998) Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/ Oncology, 20, 234-240.
70. Barr, R.D., Halton, J., Willan, A., Cockshott, W.P., Gill, G. & Atkinson, S. (1998) Impact of age and cranial irradiation on radiographic skeletal pathology in children with acute lymphoblastic leukemia. Medical Pediatric Oncology, 30, 347-350.
71. Zelissen, P.M., Croughs, R.J., van Rijk, P.P. & Raymakers, J.A. (1994) Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison's disease. Annals of International Medicine, 120, 207-210.
72. Mandel, K., Atkinson, S., Barr, R.D. & Pencharz, P. (2004) Skeletal morbidity in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 22, 1215-1221.
73. Brennan, B.M., Mughal, Z., Roberts, S.A., Ward, K., Shalet, S.M., Eden, T.O., Will, A.M., Stevens, R.F. & Adams, J.E. (2005) Bone mineral density in childhood survivors of acute lymphoblastic leukaemia treated without cranial irradiation. Journal of Clinical Endocrinology and Metabolism, 90, 689-694.
74. Davies, J.H., Evans, B.A.J. & Gregory, J.W. (2005) Bone mass acquisition in healthy children. Archives of Disease in Childhood, 90, 373-378.
75. van Beek, R.D., de Muinck Keizer-Schrama, S.M.P., van Rossum, E.F.C., Uittterlinden, A.G., Pieters, R. & van den Heul-Eibrink, M.M. (2004) Influence of genetic polymorphisms of the glucocorticoid receptor, estrogen receptor, vitamin D receptor, collagen type 1 and methyltetrahydrofolate reductase genes on bone mineral density, body composition, and fracture risk in pediatric acute lymphoblastic leukemia. Hormone Research, 62, 42.
76. Hahn, T.J., Boisseau, V.C. & Avioli, L.V. (1974) Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass. Journal of Clinical Endocrinology and Metabolism, 39, 274-282.
77. Antoniazzi, F., Bertoldo, F., Lauriola, S., Sirpresi, S., Gasperi, E., Zamboni, G. & Tato, L. (1999) Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotrophin-releasing hormone agonist treatment. Journal of Clinical Endocrinology and Metabolism, 84, 1992-1996.
78. Fuchs, R.K., Bauer, J.J. & Snow, C.M. (2001) Jumping improves hip and lumbar spine bone mass in prepubescent children: a randomized controlled trial. Journal of Bone and Mineral Research, 16, 148-156.
79. Sandler, R.B., Slemenda, C.W., LaPorte, R.E., Cauley, J.A., Schramm, M.M., Barresi, M.L. & Kriska, A.M. (1985) Postmenopausal bone density and milk consumption in childhood and adolescence. American Journal of Clinical Nutrition, 42, 270-274.
80. Specker, B. & Binkley, T. (2003) Randomized trial of physical activity and calcium supplementation on bone mineral content in 3- to 5-year-old children. Journal of Bone and Mineral Research, 18, 885-892.
81. Zamora, S.A., Rizzoli, R., Belli, D.C., Slosman, D.O. & Bonjour, J.P. (1999) Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. Journal of Clinical Endocrinology and Metabolism, 84, 4541-4544.
82. McGartland, C., Robson, P.J., Murray, L., Cran, G., Savage, M.J., Watkins, D., Rooney, M. & Boreham, C. (2003) Carbonated soft drink consumption and bone mineral density in adolescence: the Northern Ireland Young Hearts project. Journal of Bone and Mineral Research, 18, 1563-1569.
83. Barr, R.D., Guo, C.Y., Wiernikowski, J., Webber, C., Wright, M. & Atkinson, S. (2002) Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate. Medical Pediatric Oncology, 39, 44-46.
84. Henderson, R.C., Madsen, C.D., Davis, C. & Gold, S.H. (1998) Longitudinal evaluation of bone mineral density in children receiving chemotherapy. Journal of Pediatric Hematology/Oncology, 20, 322-326.
85. Aisenberg, J., Hsieh, K., Kalaitzoglou, G., Whittam, E., Heller, G., Schneider, R. & Sklar, C. (1998) Bone mineral density in young adult survivors of childhood cancer. Journal of Pediatric Hematology/ Oncology, 20, 241-245.
86. Arikoski, P., Komulainen, J., Riikonen, P., Jurvelin, J.S., Voutilainen, R. & Kroger, H. (1999) Reduced bone density at completion of chemotherapy for a malignancy. Archives of Disease in Childhood, 80, 143-148.
87. Lequin, M.H., van der Shuis, I.M., Van Rijn, R.R., Hop, W.C., van ven Huevel-Eibrink, M.M., MuinckKeizer-Schrama, S.M. & van Kuijk, C. (2002) Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood. Journal of Clinical Densitometry, 5, 167-173.